1. Effects of anti-inflammatory treatment and surgical intervention on endothelial glycocalyx, peripheral and coronary microcirculation and myocardial deformation in inflammatory bowel disease patients. (8th February 2021) Authors: Triantafyllou, C; Ikonomidis, I; Nikolaou, M; Bamias, G; Thymis, J; Kostelli, G; Kalogeris, A; Papaconstantinou, I Journal: European heart journal Issue: Volume 22(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of glucagon like peptide-1 receptor agonists and their combination with sodium-glucose cotransporter-2 inhibitors on myocardial deformation and work index in type 2 diabetes: 1 year follow up. (8th February 2021) Authors: Ikonomidis, I; Pavlidis, G; Thymis, J; Birba, D; Kalogeris, A; Kousathana, F; Kountouri, A; Balampanis, K; Parissis, J; Andreadou, I; Katogiannis, K; Frogoudaki, A; Vrettou, AR; Iliodromitis, EK; Lambadiari, V Journal: European heart journal Issue: Volume 22(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of glucagon like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on vascular function and myocardial work index in patient with type-2 diabetes. (25th November 2020) Authors: Ikonomidis, I; Pavlidis, G; Thymis, J; Birba, D; Kalogeris, A; Kousathana, F; Kountouri, A; Balampanis, K; Parissis, J; Andreadou, I; Katogiannis, K; Dimitriadis, G; Bamias, A; Iliodromitis, E; Lambadiari, V Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Glucagon like peptide-1 receptor agonists and their combination with sodium-glucose cotransporter-2 inhibitors improve myocardial deformation and work index in type-2 diabetes after 12-month treatment. (25th November 2020) Authors: Ikonomidis, I; Pavlidis, G; Thymis, J; Birba, D; Kalogeris, A; Kousathana, F; Kountouri, A; Balampanis, K; Parissis, J; Andreadou, I; Katogiannis, K; Frogoudaki, A; Vrettou, A.R; Iliodromitis, E; Lambadiari, V Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P2522The combined treatment with glucagon like peptide-1 analogues and sodium-glucose co-transporter 2 causes a greater improvement of arterial stiffness than each treatment alone in type 2 diabetes. (28th August 2018) Authors: Ikonomidis, I; Kalogeris, A; Kostelli, G; Andreou, Y; Birba, D; Thimis, I; Andreadou, I; Parissis, J; Dimitriadis, G; Kousathana, F; Varoudi, M; Triantafyllidi, H; Dimitriadis, G; Iliodromitis, E; Lambadiari, V Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P959Serum uric acid levels are associated with twenty-four hour arterial blood pressure measurements and the estimated ten-year risk of fatal cardiovascular disease. a prospective study. (28th August 2018) Authors: Kallistratos, M S; Poulimenos, L E; Giannitsi, S; Koukouzeli, A; Tsinivizov, P; Kontogiannis, N; Athanasiou, D; Kouremenos, N; Khashlok, L A; Miaris, N; Kalogeris, A; Manolis, A J Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes. (25th November 2020) Authors: Ikonomidis, I; Pavlidis, G; Thymis, J; Birba, D; Kalogeris, A; Kousathana, F; Kountouri, A; Balampanis, K; Parissis, J; Andreadou, I; Katogiannis, K; Dimitriadis, G; Bamias, A; Iliodromitis, E; Lambadiari, V Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The effect of one year treatment with GLP1-RA, SGLT2i and their combination on plasma levels of oxidative and antioxidative biomarkers. (14th October 2021) Authors: Ikonomidis, I; Thymis, J; Pavlidis, G; Birba, D; Kalogeris, A; Kousathana, F; Kountouri, A; Korakas, E; Kostelli, G; Triantafyllou, C; Triantafyllidi, H; Andreadou, I; Lambadiari, V Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The effects of empagliflozin on arterial stiffness, endothelial function and ventriculoarterial coupling in type 2 diabetes mellitus: 1 year follow up. (25th November 2020) Authors: Ikonomidis, I; Thymis, J; Pavlidis, G; Birba, D; Kalogeris, A; Kousathana, F; Kostelli, G; Triantafyllou, C; Katogiannis, K; Lampadiari, V; Iliodromitis, E.K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗